21/12/2014 20:20:26 Free Membership Login

   

Arrowhead Research Corporation

Visual Financials
Company Name: Arrowhead Research Corporation
Ticker Symbol: ARWR
WWW Address: http://www.arrowheadresearch.com
CEO: Christopher Anzalone
No. of Employees: 54
Common Issue Type: CS
Business Description:Arrowhead Research Corporation is a biopharmaceutical company developing targeted RNAi therapeutics.

 
Industry Information: DRUGS - Biotechnology [more like this]
 Price  Day Change  Bid  Ask  Open  High  Low  Volume 
 6.37 Up 0.26 6.38 6.36 6.14 6.40 6.02 4914268
 Market Cap (mil) Shares Outstanding (mil) Beta EPS DPS P/E Yield 52-Wks-Range
 348.3 54.7 0.00 -1.25 0.00 0.0 0.0 27.63 - 4.95
KEY FIGURES (Latest Twelve Months - LTM)
Yesterday's Close6.39$
PE Ratio - LTM0.0
Market Capitalisation348.3mil
Latest Shares Outstanding54.7mil
Earnings pS (EPS)-1.25$
Dividend pS (DPS)0.00¢
Dividend Yield0.0%
Dividend Payout Ratio%
Revenue per Employee$
Effective Tax Rate%
Float38.7mil
Float as % of Shares Outstanding1.0%
Foreign Salesmil
Domestic Salesmil
Selling, General & Adm/tive (SG&A) as % of Revenue139.50%
Research & Devlopment (R&D) as % of Revenue132.20%
Gross Profit Margin100.0%
EBITDA Margin-29674.6%
Pre-Tax Profit Margin0.0%
Assets Turnover0.2%
Return on Assets (ROA)-53.3%
Return on Equity (ROE)-60.4%
Return on Capital Invested (ROCI)-59.4%
Current Ratio13.1
Leverage Ratio (Assets/Equity)1.1
Interest Cover
Total Debt/Equity (Gearing Ratio)0.01
LT Debt/Total Capital0.0%
Working Capital pS2.61$
Cash pS0.00$
Book-Value pS3.05$
Tangible Book-Value pS3.03$
Cash Flow pS-0.75$
Free Cash Flow pS-0.79$
KEY FIGURES (LTM): Price info
Price/Book Ratio2.10
Price/Tangible Book Ratio0.00
Price/Cash Flow-8.5
Price/Free Cash Flow-8.1
P/E as % of Industry Group0.0%
P/E as % of Sector Segment0.0%
 
Balance Sheet (at a glance) in Millions
DIVIDEND INFO
Type of Payment-
Dividend Rate0.00
Current Dividend Yield0.0
5-Y Average Dividend Yield0.0
Payout Ratio0.0
5-Y Average Payout Ratio0.0
Share price performance previous 3 years

Share price performance intraday

 
PRICE/VOLUMEHighLowClose% Price Chg% Price Chg vs. Mkt.Avg. Daily VolTotal Vol
1 Week---6.4023.52-416
4 Weeks6.406.026.026.4023.526-60
13 Weeks6.396.3949139104.9527.636-60
26 Weeks49139106.406.405.5527.63610
52 Weeks4.954.955.9015.884.95610
YTD4.954.95-15.884.952-38
Moving Average5-Days10-Days10-Weeks30-Weeks200-DaysBeta (60-Mnth)Beta (36-Mnth)
4.954.9515.2415.2417.420.310.31
 
GROWTH RATES5-Year
Growh
R² of 5-Year Growth3-Year
Growth
Revenue491748842843357128433571
Income4917488449174884246227692
Dividend246227692445442761445442761
Capital Spending662711578NA662711578
R&D36969452NA36969452
Normalized Inc.246227692NA246227692
 
CHANGESYTD vs.
Last YTD
Curr Qtr vs.
Qtr 1-Yr ago
Annual vs.
Last Annual
Revenue %-62-85-85
Earnings %-49-49-54
EPS %101108108
EPS $-546464
 
SOLVENCY RATIOS
SHORT-TERM SOLVENCY RATIOS (LIQUIDITY)
Net Working Capital Ratio0.00
Current Ratio182816756
Quick Ratio (Acid Test)28015986
Liquidity Ratio (Cash)0.00
Receivables Turnover103125
Average Collection Period
Working Capital/Equity
Working Capital pS18
Cash-Flow pS18
Free Cash-Flow pS166540425
FINANCIAL STRUCTURE RATIOS
Altman's Z-Score Ratio0.00
Financial Leverage Ratio (Assets/Equity)2579478
Debt Ratio16831501
Total Debt/Equity (Gearing Ratio)No
LT Debt/Equity4226137
LT Debt/Capital Invested0.0
LT Debt/Total Liabilities16831501
Interest Cover-4190230
Interest/Capital Invested0.00
 
VALUATION RATIOS
MULTIPLES
PQ Ratio0.00
Tobin's Q Ratio0.00
Current P/E Ratio - LTM448,298,736.00
Enterprise Value (EV)/EBITDA-1.09
Enterprise Value (EV)/Free Cash Flow178,028.27
Dividend Yield13395037
Price/Tangible Book Ratio - LTM100
Price/Book Ratio - LTM2623102
Price/Cash Flow Ratio13.1
Price/Free Cash Flow Ratio - LTM100
Price/Sales Ratio13.00
P/E Ratio (1 month ago) - LTM448298736
P/E Ratio (26 weeks ago) - LTM579892380
P/E Ratio (52 weeks ago) - LTM579892380
5-Y High P/E Ratio663644845
5-Y Low P/E Ratio658231031
5-Y Average P/E Ratio2484885
Current P/E Ratio as % of 5-Y Average P/E2484885
P/E as % of Industry Group2,458,744.0
P/E as % of Sector Segment2,458,744.0
Current 12 Month Normalized P/E Ratio - LTM2,584,870.0
PER SHARE FIGURES
LT Debt pS972331
Current Liabilities pS
Tangible Book Value pS - LTM13.1
Book Value pS - LTM2623102
Capital Invested pS0.00
Cash pS - LTM806
Cash Flow pS - LTM1.25
Free Cash Flow pS - LTM1.25
Earnings pS (EPS)15
 
OPERATING RATIOS
PROFITABILITY RATIOS
Free Cash Flow Margin0.00
Free Cash Flow Margin 5YEAR AVG0.00
Net Profit Margin-4190230
Net Profit Margin - 5YEAR AVRG.2014-11-24
Equity Productivity0.00
Return on Equity (ROE)166540425
Return on Equity (ROE) - 5YEAR AVRG.349422044
Capital Invested Productivity0.00
Return on Capital Invested (ROCI)
Return on Capital Invested (ROCI) - 5YEAR AVRG.-100
Assets Productivity2,579,478.00
Return on Assets (ROA)
Return on Assets (ROA) - 5YEAR AVRG.349422044
Gross Profit Margin2458744
Gross Profit Margin - 5YEAR AVRG.-100
EBITDA Margin - LTM3788118
EBIT Margin - LTM2458744
Pre-Tax Profit Margin3872753
Pre-Tax Profit Margin - 5YEAR AVRG.54682636
Effective Tax Rate100.0
Effective Tax Rate - 5YEAR AVRG.100.0
EFFICIENCY RATIOS
Cash Conversion Cycle11,847,312
Revenue per Employee
Net Income per Employee1,013,473
Average Collection Period
Receivables Turnover103125
Day's Inventory Turnover Ratio11847024
Inventory Turnover103125
Inventory/Sales972331
Accounts Payble/Sales0.00
Assets/Revenue0.00
Net Working Capital Turnover0.00
Fixed Assets Turnover0.00
Total Assets Turnover2579478
Revenue per $ Cash4667992
Revenue per $ Plant4667992
Revenue per $ Common Equity
Revenue per $ Capital Invested
Selling, General & Adm/tive (SG&A) as % of Revenue
SG&A Expense as % of Revenue - 5YEAR AVRG.54682636
Research & Devlopment (R&D) as % of Revenue
R&D Expense as % of Revenue - 5YEAR AVRG.

  


Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

NYSE and AMEX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

1 site:2 us nasdaq arwr141221 20:20